Alteration of PPAR‐GAMMA (PPARG; PPARγ) and PTEN gene expression in acute myeloid leukemia patients and the promising anticancer effects of PPARγ stimulation using pioglitazone on AML cells

Abstract Background In the new era of tailored cancer treatment strategies, finding a molecule to regulate a wide range of intracellular functions is valuable. The unique property of nuclear receptor peroxisome proliferator‐activated receptor‐γ (PPARγ; PPARG) in transmitting the anti‐survival signal...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Shadi Esmaeili, Sina Salari, Vahid Kaveh, Seyed H. Ghaffari, Davood Bashash
Formato:	article
Lenguaje:	EN
Publicado:	Wiley 2021
Materias:	acute myeloid leukemia peroxisome proliferator‐activated receptor‐γ pioglitazone PPARγ PTEN Genetics QH426-470
Acceso en línea:	https://doaj.org/article/aed197166fc8429cb814142361588a75
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:aed197166fc8429cb814142361588a75
record_format	dspace
spelling	oai:doaj.org-article:aed197166fc8429cb814142361588a752021-11-21T19:38:53ZAlteration of PPAR‐GAMMA (PPARG; PPARγ) and PTEN gene expression in acute myeloid leukemia patients and the promising anticancer effects of PPARγ stimulation using pioglitazone on AML cells2324-926910.1002/mgg3.1818https://doaj.org/article/aed197166fc8429cb814142361588a752021-11-01T00:00:00Zhttps://doi.org/10.1002/mgg3.1818https://doaj.org/toc/2324-9269Abstract Background In the new era of tailored cancer treatment strategies, finding a molecule to regulate a wide range of intracellular functions is valuable. The unique property of nuclear receptor peroxisome proliferator‐activated receptor‐γ (PPARγ; PPARG) in transmitting the anti‐survival signals of the chemotherapeutic drugs has fired the enthusiasm into the application of this receptor in cancer treatment. Objectives We aimed to investigate the expression of PPARγ and one of its downstream targets PTEN in non‐M3 acute myeloid leukemia (AML) patients. We also investigated the therapeutic value of PPARγ stimulation using pioglitazone in the AML‐derived U937 cell line. Methods The blood samples from 30 patients diagnosed with non‐M3 AML as well as 10 healthy individuals were collected and the mRNA expression levels of PPARγ and PTEN were evaluated. Additionally, we used trypan blue assay, MTT assay, and flow cytometry analysis to evaluate the anti‐leukemic effects of pioglitazone on U937 cells. Results While PTEN was significantly downregulated in AML patients as compared to the control group, the expression of PPARγ was increased in the patients’ group. The expression level of PPARγ was also negatively correlated with PTEN; however, it was not statistically significant. Besides, PPARγ stimulation using pioglitazone reduced survival and proliferative capacity of U937 cells through inducing apoptosis and suppression of cell transition from the G1 phase of the cell cycle. Conclusion The results of the present study shed more light on the importance of PPARγ and its stimulation in the therapeutic strategies of AML.Shadi EsmaeiliSina SalariVahid KavehSeyed H. GhaffariDavood BashashWileyarticleacute myeloid leukemiaperoxisome proliferator‐activated receptor‐γpioglitazonePPARγPTENGeneticsQH426-470ENMolecular Genetics & Genomic Medicine, Vol 9, Iss 11, Pp n/a-n/a (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	acute myeloid leukemia peroxisome proliferator‐activated receptor‐γ pioglitazone PPARγ PTEN Genetics QH426-470
spellingShingle	acute myeloid leukemia peroxisome proliferator‐activated receptor‐γ pioglitazone PPARγ PTEN Genetics QH426-470 Shadi Esmaeili Sina Salari Vahid Kaveh Seyed H. Ghaffari Davood Bashash Alteration of PPAR‐GAMMA (PPARG; PPARγ) and PTEN gene expression in acute myeloid leukemia patients and the promising anticancer effects of PPARγ stimulation using pioglitazone on AML cells
description	Abstract Background In the new era of tailored cancer treatment strategies, finding a molecule to regulate a wide range of intracellular functions is valuable. The unique property of nuclear receptor peroxisome proliferator‐activated receptor‐γ (PPARγ; PPARG) in transmitting the anti‐survival signals of the chemotherapeutic drugs has fired the enthusiasm into the application of this receptor in cancer treatment. Objectives We aimed to investigate the expression of PPARγ and one of its downstream targets PTEN in non‐M3 acute myeloid leukemia (AML) patients. We also investigated the therapeutic value of PPARγ stimulation using pioglitazone in the AML‐derived U937 cell line. Methods The blood samples from 30 patients diagnosed with non‐M3 AML as well as 10 healthy individuals were collected and the mRNA expression levels of PPARγ and PTEN were evaluated. Additionally, we used trypan blue assay, MTT assay, and flow cytometry analysis to evaluate the anti‐leukemic effects of pioglitazone on U937 cells. Results While PTEN was significantly downregulated in AML patients as compared to the control group, the expression of PPARγ was increased in the patients’ group. The expression level of PPARγ was also negatively correlated with PTEN; however, it was not statistically significant. Besides, PPARγ stimulation using pioglitazone reduced survival and proliferative capacity of U937 cells through inducing apoptosis and suppression of cell transition from the G1 phase of the cell cycle. Conclusion The results of the present study shed more light on the importance of PPARγ and its stimulation in the therapeutic strategies of AML.
format	article
author	Shadi Esmaeili Sina Salari Vahid Kaveh Seyed H. Ghaffari Davood Bashash
author_facet	Shadi Esmaeili Sina Salari Vahid Kaveh Seyed H. Ghaffari Davood Bashash
author_sort	Shadi Esmaeili
title	Alteration of PPAR‐GAMMA (PPARG; PPARγ) and PTEN gene expression in acute myeloid leukemia patients and the promising anticancer effects of PPARγ stimulation using pioglitazone on AML cells
title_short	Alteration of PPAR‐GAMMA (PPARG; PPARγ) and PTEN gene expression in acute myeloid leukemia patients and the promising anticancer effects of PPARγ stimulation using pioglitazone on AML cells
title_full	Alteration of PPAR‐GAMMA (PPARG; PPARγ) and PTEN gene expression in acute myeloid leukemia patients and the promising anticancer effects of PPARγ stimulation using pioglitazone on AML cells
title_fullStr	Alteration of PPAR‐GAMMA (PPARG; PPARγ) and PTEN gene expression in acute myeloid leukemia patients and the promising anticancer effects of PPARγ stimulation using pioglitazone on AML cells
title_full_unstemmed	Alteration of PPAR‐GAMMA (PPARG; PPARγ) and PTEN gene expression in acute myeloid leukemia patients and the promising anticancer effects of PPARγ stimulation using pioglitazone on AML cells
title_sort	alteration of ppar‐gamma (pparg; pparγ) and pten gene expression in acute myeloid leukemia patients and the promising anticancer effects of pparγ stimulation using pioglitazone on aml cells
publisher	Wiley
publishDate	2021
url	https://doaj.org/article/aed197166fc8429cb814142361588a75
work_keys_str_mv	AT shadiesmaeili alterationofppargammappargppargandptengeneexpressioninacutemyeloidleukemiapatientsandthepromisinganticancereffectsofppargstimulationusingpioglitazoneonamlcells AT sinasalari alterationofppargammappargppargandptengeneexpressioninacutemyeloidleukemiapatientsandthepromisinganticancereffectsofppargstimulationusingpioglitazoneonamlcells AT vahidkaveh alterationofppargammappargppargandptengeneexpressioninacutemyeloidleukemiapatientsandthepromisinganticancereffectsofppargstimulationusingpioglitazoneonamlcells AT seyedhghaffari alterationofppargammappargppargandptengeneexpressioninacutemyeloidleukemiapatientsandthepromisinganticancereffectsofppargstimulationusingpioglitazoneonamlcells AT davoodbashash alterationofppargammappargppargandptengeneexpressioninacutemyeloidleukemiapatientsandthepromisinganticancereffectsofppargstimulationusingpioglitazoneonamlcells
_version_	1718418719533694976

Alteration of PPAR‐GAMMA (PPARG; PPARγ) and PTEN gene expression in acute myeloid leukemia patients and the promising anticancer effects of PPARγ stimulation using pioglitazone on AML cells

Ejemplares similares